Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial".
作者信息
Chatelain Pierre, Kjelgaard-Hansen Mads, Sprogøe Kennett
机构信息
Collège of Paediatrics, Université Claude Bernard Lyon 1, SaintGenis-Laval 69230, France.
Innovation & Research, Ascendis Pharma A/S, 2900 Hellerup, Denmark.
出版信息
J Clin Endocrinol Metab. 2023 Jul 14;108(8):e644-e645. doi: 10.1210/clinem/dgad096.
Abstract
摘要
相似文献
1
Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial".来自沙泰兰等人致编辑的信：“每周一次索马培坦对生长激素缺乏症儿童有效且耐受性良好：随机3期REAL4试验”
J Clin Endocrinol Metab. 2023 Jul 14;108(8):e644-e645. doi: 10.1210/clinem/dgad096.
2
Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial".对Chatelain等人致编辑信的回复：“每周一次索马帕西坦对生长激素缺乏症儿童有效且耐受性良好：随机3期REAL4试验”
J Clin Endocrinol Metab. 2023 Jul 14;108(8):e647-e648. doi: 10.1210/clinem/dgad095.
3
Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial.每周索马帕坦治疗儿童生长激素缺乏症的疗效和耐受性良好：随机 3 期 REAL4 试验。
J Clin Endocrinol Metab. 2022 Nov 25;107(12):3378-3388. doi: 10.1210/clinem/dgac513.
4
Effective growth hormone replacement with once-weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial.每周一次somapacitan 治疗生长激素缺乏症日本儿童的有效生长激素替代：REAL4 阶段 3 临床试验结果。
Clin Endocrinol (Oxf). 2024 Apr;100(4):389-398. doi: 10.1111/cen.15025. Epub 2024 Feb 18.
5
Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH.索马帕坦治疗儿童生长激素缺乏症的疗效：REAL4 研究 2 年结果及由每日 GH 转换治疗后的随访
J Clin Endocrinol Metab. 2023 Nov 17;108(12):3090-3099. doi: 10.1210/clinem/dgad394.
6
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.每周一次索马帕肽治疗成人生长激素缺乏症的有效性和耐受性：一项随机 3 期试验。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1358-76. doi: 10.1210/clinem/dgaa049.
7
Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.索马帕坦，一种每周一次的可还原白蛋白结合型 GH 衍生物，用于治疗儿童生长激素缺乏症：一项随机剂量递增试验。
Clin Endocrinol (Oxf). 2017 Oct;87(4):350-358. doi: 10.1111/cen.13409. Epub 2017 Aug 8.
8
Gene Expression Signatures Predict First-Year Response to Somapacitan Treatment in Children With Growth Hormone Deficiency.基因表达谱可预测生长激素缺乏症儿童对索马帕肽治疗的首年应答。
J Clin Endocrinol Metab. 2024 Apr 19;109(5):1214-1221. doi: 10.1210/clinem/dgad717.
9
Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.每周一次索马帕坦治疗成人生长激素缺乏症的安全性和便利性：26 周随机对照试验。
Eur J Endocrinol. 2018 May;178(5):491-499. doi: 10.1530/EJE-17-1073. Epub 2018 Mar 2.
10
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.每周一次的索马帕肽与每日生长激素治疗生长激素缺乏症儿童：一项随机 2 期试验结果。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1847-61. doi: 10.1210/clinem/dgz310.
引用本文的文献
1
Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial".对Chatelain等人致编辑信的回复：“每周一次索马帕西坦对生长激素缺乏症儿童有效且耐受性良好：随机3期REAL4试验”
J Clin Endocrinol Metab. 2023 Jul 14;108(8):e647-e648. doi: 10.1210/clinem/dgad095.
本文引用的文献
1
What do we do now that the long-acting growth hormone is here?长效生长激素问世了，我们现在该怎么办？
Front Endocrinol (Lausanne). 2022 Aug 22;13:980979. doi: 10.3389/fendo.2022.980979. eCollection 2022.
2
Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial.每周索马帕坦治疗儿童生长激素缺乏症的疗效和耐受性良好：随机 3 期 REAL4 试验。
J Clin Endocrinol Metab. 2022 Nov 25;107(12):3378-3388. doi: 10.1210/clinem/dgac513.
3
Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.每周使用 lonapegsomatropin 治疗初治生长激素缺乏症儿童：第 3 阶段 heiGHt 试验。
J Clin Endocrinol Metab. 2021 Oct 21;106(11):3184-3195. doi: 10.1210/clinem/dgab529.
4
A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency.长效转甲状腺素蛋白生长激素（TransCon GH）与每日生长激素（GH）治疗儿童生长激素缺乏症的随机2期研究。
J Clin Endocrinol Metab. 2017 May 1;102(5):1673-1682. doi: 10.1210/jc.2016-3776.
Zotero 插件